U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C23H32N3O10P.2Na.2H2O
Molecular Weight 623.4981
Optical Activity UNSPECIFIED
Defined Stereocenters 7 / 7
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of PHOSPHORAMIDON DISODIUM DIHYDRATE

SMILES

O.O.[Na+].[Na+].CC(C)C[C@H](NP([O-])(=O)O[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O)C(=O)N[C@@H](CC2=CNC3=C2C=CC=C3)C([O-])=O

InChI

InChIKey=RUUVTTHDXFLIFU-HIKRQZGHSA-L
InChI=1S/C23H34N3O10P.2Na.2H2O/c1-11(2)8-16(26-37(33,34)36-23-20(29)19(28)18(27)12(3)35-23)21(30)25-17(22(31)32)9-13-10-24-15-7-5-4-6-14(13)15;;;;/h4-7,10-12,16-20,23-24,27-29H,8-9H2,1-3H3,(H,25,30)(H,31,32)(H2,26,33,34);;;2*1H2/q;2*+1;;/p-2/t12-,16-,17-,18-,19+,20+,23-;;;;/m0..../s1

HIDE SMILES / InChI

Molecular Formula Na
Molecular Weight 22.98976928
Charge 1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula HO
Molecular Weight 17.0073
Charge -1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C23H34N3O10P
Molecular Weight 543.5039
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 7 / 7
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Targets
PubMed

PubMed

TitleDatePubMed
Essential role for vascular gelatinase activity in relaxin-induced renal vasodilation, hyperfiltration, and reduced myogenic reactivity of small arteries.
2003-12-12
Active amino acids of the Kell blood group protein and model of the ectodomain based on the structure of neutral endopeptidase 24.11.
2003-10-15
Aminopeptidases function as endocytic receptors in the trophotaenial placenta of the goodeid fish, Ameca splendens (Teleostei: Atheriniformes).
2003-10-01
Metalloendopeptidase inhibition regulates phosphorylation of p38-mitogen-activated protein kinase and nitric oxide synthase in heart after endotoxemia.
2003-10
CD10 is a key enzyme involved in the activation of tumor-activated peptide prodrug CPI-0004Na and novel analogues: implications for the design of novel peptide prodrugs for the therapy of CD10+ tumors.
2003-09-01
The role of endothelin converting enzyme inhibition during group B streptococcus-induced pulmonary hypertension in newborn piglets.
2003-09
Cerebral angiogenesis and expression of VEGF after subarachnoid hemorrhage (SAH) in rats.
2003-08-15
The effects of phosphoramidon on the expression of human endothelin-converting enzyme-1 (ECE-1) isoforms.
2003-07
[D-Val22]big ET-1[16-38] inhibits endothelin-converting enzyme activity: a promising concept in the prevention of cerebral vasospasm.
2003-05
Pathways and kinetics of deslorelin degradation in an airway epithelial cell line (Calu-1).
2003-05
Crucial role of extracellular signal-regulated kinase pathway in reactive oxygen species-mediated endothelin-1 gene expression induced by endothelin-1 in rat cardiac fibroblasts.
2003-05
Vasospasm following subarachnoid hemorrhage: evidence against functional upregulation of protein kinase C constrictor pathway.
2003-04
Pseudomonas aeruginosa elastase degrades surfactant proteins A and D.
2003-04
Binding of a new bioactive 31-amino-acid endothelin-1 to an endothelin ET(B) or ET(B)-like receptor in porcine lungs.
2003-03-28
Peptidases prevent mu-opioid receptor internalization in dorsal horn neurons by endogenously released opioids.
2003-03-01
The formyl peptide N-formyl-methionyl-leucyl-phenylalanine downregulates the expression of FcgammaRs in interferon-gamma-activated monocytes/macrophages in vitro and in vivo.
2003-03
Identification and localization of a neprilysin-like activity that degrades tachykinin-related peptides in the brain of the cockroach, Leucophaea maderae, and locust, Locusta migratoria.
2003-02-24
Effect of endothelin-1 (1-31) on the renal resistance vessels.
2003-02
Effects of kinins on mammalian spermatozoa and the impact of peptidolytic enzymes.
2003-02
Role of tachykinins in the bronchoconstriction induced by HCl intraesophageal instillation in the rabbit.
2003-01-24
Action of three ectopeptidases on corticotropin-releasing factor: metabolism and functional aspects.
2003-01
Mechanical stretch-induced mitogen-activated protein kinase activation is mediated via angiotensin and endothelin systems in vascular smooth muscle cells.
2002-12
High-performance liquid chromatographic separation of renin-angiotensin system peptides and most of their metabolic fragments.
2002-11-25
Attenuation of ischemia/reperfusion induced MAP kinases by N-acetyl cysteine, sodium nitroprusside and phosphoramidon.
2002-11
Combination therapy of N-acetylcysteine, sodium nitroprusside and phosphoramidon attenuates ischemia-reperfusion injury in rat kidney.
2002-11
Effect of endothelin-converting enzyme inhibitors on big endothelin-1 induced contraction in isolated rat basilar artery.
2002-11
Extracellular peptidases of imaginal discs of Drosophila melanogaster.
2002-11
The mechanisms for tachykinin-induced contractions of the rabbit corpus cavernosum.
2002-11
Cardioprotective effects of phosphoramidon on myocardial structure and function in murine Chagas' disease.
2002-11
Role of abnormal neutral endopeptidase-like activities in Hyp mouse bone cells in renal phosphate transport.
2002-11
[Met5]enkephalin-Arg-Gly-Leu-induced antinociception is greatly increased by peptidase inhibitors.
2002-10-18
Degradation of nociceptin (orphanin FQ) by mouse spinal cord synaptic membranes is triggered by endopeptidase-24.11: an in vitro and in vivo study.
2002-10-15
The increased proliferation of cultured neuroblastoma cells treated with vasoactive intestinal peptide is enhanced by simultaneous inhibition of neutral endopeptidase.
2002-10-15
Mycosin-1, a subtilisin-like serine protease of Mycobacterium tuberculosis, is cell wall-associated and expressed during infection of macrophages.
2002-10-07
Attenuation of renal ischemia/reperfusion injury by a triple drug combination therapy.
2002-09-03
Effect of quercetin on plasma extravasation in rat CNS and dura mater by ACE and NEP inhibition.
2002-09
Bradykinin potentiation by ACE inhibitors: a matter of metabolism.
2002-09
Induction of apoptosis and CD10/neutral endopeptidase expression by jaspamide in HL-60 line cells.
2002-08
Tachykinins and airway microvascular leakage induced by HCl intra-oesophageal instillation.
2002-08
Phosphoramidon treatment improves the consequences of chagasic heart disease in mice.
2002-08
Expression, purification and characterization of the monomeric and dimeric forms of soluble bovine endothelin converting enzyme-1a.
2002-08
Characterization of PgPepO, a bacterial homologue of endothelin-converting enzyme-1.
2002-08
Endothelin-converting enzyme activity in human cerebral circulation.
2002-08
Effect of glycerol on endothelium-derived factors in the vasculature of the rabbit kidney.
2002-08
Possible involvement of placental peptidases that degrade gonadotropin-releasing hormone (GnRH) in the dynamic pattern of placental hCG secretion via GnRH degradation.
2002-07
Pressor and pulmonary responses to ET-1(1-31) in guinea-pigs.
2002-07
Vasospasm following subarachnoid hemorrhage: evidence against functional upregulation of Rho kinase constrictor pathway.
2002-06
Efficient transesterification of sucrose catalysed by the metalloprotease thermolysin in dimethylsulfoxide.
2002-05-22
Vascular endothelin converting enzyme-1 expression and activity is upregulated in clinical diabetes.
2002
Endothelin-converting enzyme activity in vascular smooth muscle preparations in vitro.
2002
Patents
Substance Class Chemical
Created
by admin
on Mon Mar 31 22:17:53 GMT 2025
Edited
by admin
on Mon Mar 31 22:17:53 GMT 2025
Record UNII
1Y1FE6YEU5
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
PHOSPHORAMIDON DISODIUM DIHYDRATE
Common Name English
L-TRYPTOPHAN, N-(((6-DEOXY-.ALPHA.-L-MANNOPYRANOSYL)OXY)HYDROXYPHOSPHINYL)-L-LEUCYL-, DISODIUM SALT, DIHYDRATE
Preferred Name English
Code System Code Type Description
PUBCHEM
91617739
Created by admin on Mon Mar 31 22:17:53 GMT 2025 , Edited by admin on Mon Mar 31 22:17:53 GMT 2025
PRIMARY
FDA UNII
1Y1FE6YEU5
Created by admin on Mon Mar 31 22:17:53 GMT 2025 , Edited by admin on Mon Mar 31 22:17:53 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY